Anatomy and Physiology I (BIO 2010)

Correct Answer B. Asthma

Explanation

Nasal flaring is a sign of increased respiratory effort, commonly seen in conditions like asthma where airway obstruction makes breathing more difficult. It is especially prevalent in children experiencing respiratory distress.

Why Other Options Are Wrong

A. Hypertension

High blood pressure does not directly cause nasal flaring. While severe hypertension may lead to shortness of breath, it is not a primary cause of nasal flaring.

C. Diabetes

Diabetes affects blood sugar regulation but does not typically cause respiratory distress leading to nasal flaring. However, in extreme cases like diabetic ketoacidosis (DKA), rapid breathing (Kussmaul respiration) may occur, but this is different from asthma-related nasal flaring.

D. Gastroesophageal reflux disease

GERD can cause symptoms like coughing and wheezing due to acid irritation, but it does not usually lead to nasal flaring. Nasal flaring is primarily a sign of respiratory distress rather than digestive issues.

Correct Answer B. They produce surfactant to lower surface tension

Explanation

Type II alveolar cells play a crucial role in lung function by synthesizing and secreting pulmonary surfactant. This surfactant decreases surface tension within the alveoli, preventing their collapse and ensuring efficient gas exchange.

Why Other Options Are Wrong

A. They are responsible for gas exchange

Gas exchange is the primary function of type I alveolar cells, not type II cells. Type I cells form the thin walls of the alveoli, allowing oxygen and carbon dioxide to diffuse between the air and blood.

C. They help in the immune response

Although the lungs have immune defense mechanisms, type II alveolar cells are not primarily responsible for immunity. Alveolar macrophages play a key role in defending against infections.

D. They transport carbon dioxide

Type II alveolar cells do not directly transport carbon dioxide. Gas transport occurs via red blood cells and plasma, with exchange occurring at the alveolar-capillary interface.

Correct Answer B. The accumulation of fluid in the pleural cavity.

Explanation

Pleural effusion occurs when excess fluid collects in the space between the pleura, the membranes surrounding the lungs. This can result from infections, heart failure, cancer, or other conditions that disrupt normal pleural fluid balance. If untreated, it can impair lung expansion and cause breathing difficulties.

Why Other Options Are Wrong

A. A condition characterized by the presence of air in the pleural cavity.

The presence of air in the pleural cavity is known as a pneumothorax, not a pleural effusion. Pneumothorax leads to lung collapse due to the loss of negative pressure, while pleural effusion primarily involves fluid buildup.

C. An infection in the pleural space.

An infection in the pleural space is known as empyema, which is a complication of pneumonia or other infections. While some pleural effusions can be caused by infections, not all are infectious in nature.

D. A type of lung cancer.

Lung cancer can lead to pleural effusion (malignant pleural effusion), but the effusion itself is not a type of cancer. Instead, it is a secondary condition caused by the cancer's impact on pleural fluid dynamics.

Correct Answer A. The epithelial layer, leading to increased mucus production and airway obstruction.

Explanation

Chronic bronchitis is characterized by inflammation of the bronchial epithelium, leading to excessive mucus production and airway narrowing. This results in chronic cough, sputum production, and airflow limitation, making breathing more difficult. Over time, cilia function is impaired, further reducing mucus clearance.

Why Other Options Are Wrong

B. The lamina propria, resulting in reduced structural integrity and increased risk of infection.

The lamina propria does play a role in inflammation, but the primary issue in chronic bronchitis is excessive mucus production in the epithelial layer. While infection is a secondary risk, it is not the main pathological feature.

C. The cartilaginous layer, causing airway collapse during expiration.

Cartilage supports large airways, but chronic bronchitis primarily affects the mucosa and submucosa. Airway collapse during expiration is more characteristic of emphysema, not chronic bronchitis.

D. The epithelial layer, reducing gas exchange efficiency due to thickening.

While thickening may occur, gas exchange happens in the alveoli, not the bronchial epithelium. Chronic bronchitis affects airflow but does not directly impair alveolar oxygen-carbon dioxide exchange.

Correct Answer D. Oxygen therapy

Explanation

Oxygen therapy is used to improve oxygenation but does not directly assist in mobilizing or removing secretions. Respiratory therapy modalities aimed at secretion clearance typically include techniques like chest physiotherapy, nebulization, and suctioning.

Why Other Options Are Wrong

A. Chest physiotherapy

This therapy includes postural drainage, percussion, and vibration to help loosen mucus in the lungs, making it easier to expectorate. It is a common intervention for patients with cystic fibrosis and chronic bronchitis.

B. Nebulized medications

Nebulized bronchodilators, mucolytics, and hypertonic saline help loosen mucus and reduce airway inflammation, facilitating secretion clearance. This therapy is frequently used in conjunction with chest physiotherapy.

C. Suctioning

Suctioning removes secretions from the upper airways, particularly in patients with impaired cough reflexes, such as those on mechanical ventilation. It is commonly used in intensive care settings to prevent mucus buildup.

Correct Answer B. Elastance would increase and compliance would decrease.

Explanation

Pulmonary fibrosis leads to lung tissue scarring and stiffening, making the lungs more resistant to expansion. This increases elastance, which refers to the lung’s ability to return to its original shape, while compliance decreases, meaning the lungs become harder to inflate. As a result, affected individuals experience restrictive lung disease with reduced lung volumes and increased work of breathing.

Why Other Options Are Wrong

A. Elastance would decrease and compliance would increase.

This pattern is seen in conditions like emphysema, where lung tissue loses its elasticity, resulting in decreased elastance and increased compliance. In fibrosis, however, the opposite occurs due to stiffened lung tissue.

C. Both elastance and compliance would remain unchanged.

Lung diseases always affect lung mechanics. In pulmonary fibrosis, both elastance and compliance are significantly altered, making this answer incorrect.

D. Elastance would decrease and compliance would decrease.

While compliance does decrease, elastance actually increases in fibrosis. Elastance refers to how well the lungs recoil after expansion, and in fibrosis, this recoil ability is abnormally high due to tissue stiffness.

Correct Answer A. An abnormal accumulation of fluid in the pleural cavity.

Explanation

Pleural effusion occurs when excess fluid builds up between the visceral and parietal pleura, limiting lung expansion and causing breathing difficulty. It can result from heart failure, infections, malignancies, or inflammatory diseases. Diagnosis is confirmed via imaging and sometimes requires thoracentesis to remove excess fluid.

Why Other Options Are Wrong

B. A pretty big deal.

While pleural effusion can be a serious condition, this answer is informal and lacks medical accuracy. A precise definition is necessary for clinical understanding and treatment planning.

C. The process of gas exchange.

Gas exchange takes place in the alveoli, not in the pleural space. Pleural effusion can impair breathing by restricting lung expansion, but it does not directly affect the oxygen-carbon dioxide exchange process.

D. Accumulation of fluid in the lungs.

Fluid accumulation inside the lungs is known as pulmonary edema, not pleural effusion. Pleural effusion refers specifically to fluid outside the lung, within the pleural cavity, whereas pulmonary edema affects the alveolar spaces.

Correct Answer B. The male urethra is longer and more complex, extending from the bladder through the penis. The female urethra is shorter and straight, only carrying urine from the bladder to the outside.

Explanation

The male urethra serves both urinary and reproductive functions, extending through the prostate and penis, making it longer and more complex. The female urethra is shorter and exclusively carries urine, making it more prone to urinary tract infections. The difference in urethral length and structure contributes to varying susceptibility to infections and other urinary conditions.

Why Other Options Are Wrong

A. The male urethra is shorter and straight.

The male urethra is not shorter; it is significantly longer than the female urethra, measuring approximately 18–20 cm compared to 4–5 cm in females. Its length is due to its dual function in urine and semen transport, unlike the female urethra, which only transports urine.

C. Both male and female urethras have the same structure.

The male and female urethras do not have the same structure. The male urethra has distinct segments, including the prostatic, membranous, and spongy parts, whereas the female urethra is short and straight. The structural differences result in functional and clinical variations, such as a higher UTI risk in females.

D. The female urethra is longer than the male urethra.

The female urethra is not longer than the male urethra. A longer urethra is a characteristic of the male anatomy, reducing the risk of infections by preventing bacterial entry. In contrast, the shorter female urethra makes it easier for bacteria to travel to the bladder, increasing UTI risk.

Correct Answer D. Covers ~95% of alveolar surface

Explanation

Type II pneumocytes are responsible for surfactant production and can proliferate into type I pneumocytes when needed. However, they do not cover 95% of the alveolar surface—this function belongs to type I pneumocytes, which form the thin epithelial lining for gas exchange.

Why Other Options Are Wrong

A. Synthesize pulmonary surfactants

This statement is true. Type II pneumocytes are the primary source of surfactant, which prevents alveolar collapse and reduces surface tension.

B. Secrete cytokines

This statement is also true. Type II pneumocytes contribute to lung immunity by secreting cytokines, which help regulate inflammation and immune responses.

C. Proliferate into type I cells

Correct as well. Type II cells can differentiate into type I cells when alveolar damage occurs, helping in lung repair and regeneration.